Partner Judith Waltz was quoted in a Bloomberg Law article, “Opening a Medicare Home-Health Agency in Texas? Think Again,” about how elevated fraud and abuse concerns led Medicare to extend an enrollment prohibition on new agencies in six states.
Waltz said home-health agencies are hard to keep track of and can be prone to fraud risks. “I think the idea behind the moratoria is that these are easy-to-access sectors, that enrollment won’t screen them out effectively, and that it takes time for the CMS to catch up with fraudulent providers,” she said.
Waltz said home-health agencies are hard to keep track of and can be prone to fraud risks. “I think the idea behind the moratoria is that these are easy-to-access sectors, that enrollment won’t screen them out effectively, and that it takes time for the CMS to catch up with fraudulent providers,” she said.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”